Renaissance BioScience Corp., a global leader in yeast bioengineering, has appointed Dr. James Tansey to its Board of Directors, the company announced July 30, 2026. Dr. Tansey brings extensive experience in life sciences, technology commercialization, fundraising and corporate governance, which will be instrumental as Renaissance continues to develop and commercialize its yeast-produced RNA and virus-like particle (VLP) platforms for crop protection and potential applications in animal and human health.
Dr. Tansey is a professor at the University of British Columbia's Sauder School of Business and previously taught at Oxford University's Saïd Business School. He is a member of the founding team at Gemina Labs, where he supports fundraising, business development and shareholder strategy. He also serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a senior advisor to InBC, British Columbia's $500 million strategic investment fund.
“We are delighted to welcome Dr. Tansey to the Renaissance Board of Directors,” said Maurice Boucher, Renaissance Co-Founder and Executive Chairman. “James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow.” Mr. Boucher added, “James has consistently focused on 'Impact Investing' and environmental protection and sustainability throughout his exceptional career, which fits well with the positive environmental impact of Renaissance's technology platforms. His expertise will be a valuable asset for Renaissance as we continue developing and globally commercializing our biotechnology platforms.”
Dr. Tansey said: “Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value.”
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, commented: “We are excited to welcome Dr. Tansey to our board. His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms.”
Based in Vancouver, Canada, Renaissance BioScience Corp. is a global-leading yeast bioengineering company developing innovative, market-ready, functional microorganisms that provide cost-effective innovative solutions to address environmental and industrial challenges in agriculture, food, nutrition, and animal and human health. For more information, visit www.renaissancebioscience.com.
